EP2240188A1 - Salbe auf der basis eines dialysats aus kälberblut - Google Patents
Salbe auf der basis eines dialysats aus kälberblutInfo
- Publication number
- EP2240188A1 EP2240188A1 EP08706951A EP08706951A EP2240188A1 EP 2240188 A1 EP2240188 A1 EP 2240188A1 EP 08706951 A EP08706951 A EP 08706951A EP 08706951 A EP08706951 A EP 08706951A EP 2240188 A1 EP2240188 A1 EP 2240188A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- ointment
- skin
- alpha
- delta
- gamma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/983—Blood, e.g. plasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Definitions
- Topical retinoid Derived from vitamin A, retinoid that you apply to the skin may be able to reduce fine wrinkles, splotchy pigmentation and skin roughness. Retinoid must be used with a skin-care program that includes sunscreen and protective clothing because the medication can make the skin bum more easily. It may also cause redness, dryness, itching, and a burning or tingling sensation.
- Nonprescription wrinkle creams The effectiveness of anti-wrinkle creams depends in part on the active ingredient or ingredients. Retinol, alpha hydroxy acids, kinetin, coenzyme QlO, copper peptides and antioxidants may result in slight to modest improvements in wrinkles. Surgical procedures and other techniques
- Microdermabrasion This technique is similar to dermabrasion, but less surface skin is removed. It's done using a vacuum suction over the face while aluminum oxide crystals essentially sandblast the skin. Microdermabrasion usually requires repeated treatments to maintain the subtle, temporary results.
- Laser, light source and radio frequency treatments In laser resurfacing, a laser beam destroys the outer layer of skin (epidermis) and heats the underlying skin (dermis), which stimulates the growth of new collagen fibers. As the wound heals, new skin forms that's smoother and tighter. It can take up to several months to fully heal from laser resurfacing. Less intense lasers (nonablative lasers), pulsed light sources and radio frequency devices don't injure the epidermis. These treatments heat the dermis and cause new collagen and elastin formation. After several treatments, skin feels firmer and appears refreshed. This means shorter recovery times, but treatment typically needs to be repeated more often and results are subtle.
- Botulinum toxin type A Botox
- Botox When injected in small doses into specific muscles, Botox blocks the chemical signals that cause muscles to contract. When the muscles can't tighten, the skin flattens and appears smoother and less wrinkled. Botox works well on frown lines between the eyebrows and across the forehead, and crow's-feet at the corners of the eyes. Results typically last about three to four months. Repeat injections are needed to maintain results.
- Soft tissue fillers which include fat, collagen and hyaluronic acid , can be injected into deeper wrinkles on your face. They plump and smooth out wrinkles and furrows and give the skin more volume. The procedure may need to be repeated every few months.
- Face-lift The face-lift procedure involves removing excess skin and fat in the lower face and neck and tightening the underlying muscle and connective tissue. The results typically last five to 10 years. Healing times can be lengthy after a face-lift. Bruising and swelling are usually evident for two to three weeks after surgery.
- A- Wrinkles are a natural part of aging, skin gets thinner, drier and less elastic. And it becomes less able to protect itself from damage. As a result, wrinkles, lines and creases form in the skin. Although genetics are the most important determiner of skin texture, a major contributor to wrinkles is spending too much time in the sun. Smoking also can negatively affect how the skin looks.
- Wrinkles are caused by a combination of factors:
- UV light Exposure to ultraviolet (UV) light.
- UV light breaks down the skin's connective tissue — collagen and elastin fibers, which lie in the deeper layer of skin (dermis). Without the supportive connective tissue, the skin loses its strength and flexibility. As a result, skin begins to sag and wrinkle prematurely.
- Smoking can accelerate the normal aging process of the skin, contributing to wrinkles. This may be due to changes in the blood supply to the skin around the lips.
- B-A new ointment in two concentration composed of 70% Vaseline in oily solution (paraffin, almond oil, bees wax, perfume) as a base to which two substances were added:
- Substance 1 vitamin E describes a family of eight antioxidants, four tocopherols, alpha-, beta-, gamma- and delta-, and four tocotrienols (also alpha-, beta-, gamma- and delta-).
- Alpha-tocopherol is the only form of vitamin E that is actively maintained in the human body and is therefore, the form of vitamin E found in the largest quantities in the blood and tissue.
- the fat-soluble vitamin, alpha-tocopherol is uniquely suited to intercepting free radicals and preventing a chain reaction of lipid destruction. Aside from maintaining the integrity of cell membranes throughout the body, alpha-tocopherol also protects the fats in low density lipoproteins (LDLs) from oxidation.
- LDLs low density lipoproteins
- Substance 2 Protein-free haemodialysate of calves' blood (Bos Taurus) chemically and biologically standardized 42.5 mg/ml. It is a tissue metabolism activator, chemically and biologically standardized - deproteinised, non antigenic and apyrogenic hemodialized extract form the blood of healthy young calf. It contains large amounts of natural low molecular weight substances - glycolipides, nucleosides, nucleotides, amino acids, oligopeptides, irreplaceable microelements, electrolytes, intervening products of carbohydrate and fat metabolism.
- the low concentration SE CARE ointment has the ability of revitalize skin and abolishing skin wrinkling significantly
- the high concentration SE CARE ointment has the ability to promote scalp hair growth and healing of persistent ulcers.
- Ointment base (SE CARE) composed of 70% Vaseline in oily solution (paraffin, almond oil, bees wax, perfume) as a base to which two substances were added: a-Adding to every lOOgm of the base ointment 1 gm of substance 1 (vitaminE ⁇ and o. lgm of subtance2 (Protein-free haemodialysate of calves' blood (Bos Taurus) chemically and biologically standardized 42.5 mg/ml) a new ointment are created (SE CAREl) which when applied once daily on the skin has the ability to revitalize the skin and reduce the skin wrinkles significantly within three month.
- SE CAREl composed of 70% Vaseline in oily solution (paraffin, almond oil, bees wax, perfume) as a base to which two substances were added: a-Adding to every lOOgm of the base ointment 1 gm of substance 1 (vitaminE ⁇ and o. lgm of subt
- A-Ointment base (SE CARE) composed of 70% Vaseline in oily solution (paraffin, almond oil, bees wax, perfume) as a base to which two substances were added
- B- substance 1 vitamin E describes a family of eight antioxidants, four tocopherols, alpha-, beta-, gamma- and delta-, and four tocotrienols (also alpha-, beta-, gamma- and delta-).
- C- substance2 Protein-free haemodialysate of calves 1 blood (Bos Taurus) chemically and biologically standardized 42.5 mg/ml
- Manufactured To Be Used as a topical treatment has the ability to revitalized the skin and reduce the skin wrinkles significantly, the ability to promote healing of persistent ulcer and to stimulate scalp hair growth.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EG2008010173 | 2008-01-30 | ||
PCT/EG2008/000010 WO2009095028A1 (en) | 2008-01-30 | 2008-02-21 | Ointment on the basis of a dialysate of calves' blood. |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2240188A1 true EP2240188A1 (de) | 2010-10-20 |
EP2240188A4 EP2240188A4 (de) | 2013-05-01 |
Family
ID=40912296
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP08706951.4A Withdrawn EP2240188A4 (de) | 2008-01-30 | 2008-02-21 | Salbe auf der basis eines dialysats aus kälberblut |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2240188A4 (de) |
JP (1) | JP2011510935A (de) |
WO (1) | WO2009095028A1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105456166A (zh) * | 2015-12-21 | 2016-04-06 | 太仓张根木生物科技有限公司 | 一种抗皱保湿爽肤水 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63135309A (ja) * | 1986-11-28 | 1988-06-07 | Shiseido Co Ltd | 皮膚外用剤 |
JPH0491009A (ja) * | 1990-08-07 | 1992-03-24 | Kanebo Ltd | 皮膚化粧料 |
JPH06128138A (ja) * | 1992-10-15 | 1994-05-10 | Kyowa Hakko Kogyo Co Ltd | 化粧料 |
US5486353A (en) * | 1993-09-29 | 1996-01-23 | Solco Basel Ag | Antisun product |
DE10156297A1 (de) * | 2001-11-19 | 2003-05-28 | Henkel Kgaa | Mittel zum Schutz der Haut |
US20040191196A1 (en) * | 2002-12-16 | 2004-09-30 | Dov Tamarkin | Novel conjugate compounds and dermatological compositions thereof |
US20060134046A1 (en) * | 2004-12-21 | 2006-06-22 | Ibrahim Hanna | Skin nourishing and moisturizing cream |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2757937A1 (de) * | 1977-12-24 | 1979-06-28 | Byk Gulden Lomberg Chem Fab | Hautpflegemittel |
DE3042999C2 (de) * | 1980-11-14 | 1984-05-10 | Solco Basel AG, Birsfelden | Verfahren zur Herstellung eines Hautkosmetikums |
DE4113346A1 (de) * | 1991-04-24 | 1992-10-29 | Lang Erich | Zubereitung zur kraeftigung und regeneration des haarwuchses |
-
2008
- 2008-02-21 JP JP2010544583A patent/JP2011510935A/ja not_active Withdrawn
- 2008-02-21 WO PCT/EG2008/000010 patent/WO2009095028A1/en active Application Filing
- 2008-02-21 EP EP08706951.4A patent/EP2240188A4/de not_active Withdrawn
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63135309A (ja) * | 1986-11-28 | 1988-06-07 | Shiseido Co Ltd | 皮膚外用剤 |
JPH0491009A (ja) * | 1990-08-07 | 1992-03-24 | Kanebo Ltd | 皮膚化粧料 |
JPH06128138A (ja) * | 1992-10-15 | 1994-05-10 | Kyowa Hakko Kogyo Co Ltd | 化粧料 |
US5486353A (en) * | 1993-09-29 | 1996-01-23 | Solco Basel Ag | Antisun product |
DE10156297A1 (de) * | 2001-11-19 | 2003-05-28 | Henkel Kgaa | Mittel zum Schutz der Haut |
US20040191196A1 (en) * | 2002-12-16 | 2004-09-30 | Dov Tamarkin | Novel conjugate compounds and dermatological compositions thereof |
US20060134046A1 (en) * | 2004-12-21 | 2006-06-22 | Ibrahim Hanna | Skin nourishing and moisturizing cream |
Non-Patent Citations (2)
Title |
---|
Deite C.: "A Practical Treatise on the Manufacture of Perfumery:", , 1892, XP002694059, Philadelphia Retrieved from the Internet: URL:http://ia700504.us.archive.org/8/items/practicaltreatis00deitrich/practicaltreatis00deitrich.pdf [retrieved on 2013-03-14] * |
See also references of WO2009095028A1 * |
Also Published As
Publication number | Publication date |
---|---|
JP2011510935A (ja) | 2011-04-07 |
WO2009095028A1 (en) | 2009-08-06 |
EP2240188A4 (de) | 2013-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Farris | Topical vitamin C: a useful agent for treating photoaging and other dermatologic conditions | |
Ehrlich et al. | Improvement in the appearance of wrinkles with topical transforming growth factor β1 and L-ascorbic acid | |
TW200412992A (en) | Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto | |
GB2451224A (en) | Cosmetic composition comprising an exfoliant, astringent, antioxidant and moisturiser | |
KR100673044B1 (ko) | 경피 투여용 국소 조성물 | |
KR20190013101A (ko) | 흉터의 예방 또는 치료를 위한 조성물 | |
CN113645985A (zh) | 用于治疗性皮肤处理的方法、组合物、片材 | |
US20110166222A1 (en) | Vitamin c composition for use in the prevention and treatment of stretch marks, radiation dermatitis, and other skin conditions and methods of using the same | |
KR20170130742A (ko) | 피부 재생용 화장품 조성물 | |
US20130202540A1 (en) | Method for repair of acute and chronic injury, such as burned and photodamaged skin | |
Fibrich et al. | Fighting the inevitable: skin aging and plants | |
WO2009095028A1 (en) | Ointment on the basis of a dialysate of calves' blood. | |
CN113693966B (zh) | 一种美白淡斑亮采霜及其制备方法 | |
Mohan et al. | Dermaroller in dermatology and cosmetology | |
RU2352329C1 (ru) | Способ лечения возрастных и косметических дефектов кожи лица | |
da Mota Silveira et al. | Synergistic therapy for skin aging: The association of the microneedling technique and vitamin C from the point of view of orofacial harmonization | |
US8969411B2 (en) | Vitamin C composition for use in the prevention and treatment of stretch other skin conditions and methods of using the same | |
KR20130017871A (ko) | 리놀렌산을 유효성분으로 포함하는 백반증 치료용 화장품 조성물 | |
RU2325900C2 (ru) | Состав для кожи наружного применения | |
Singh-Behl et al. | Chemical peels | |
De Padova et al. | Biorevitalization and combination techniques | |
TWI664973B (zh) | 荷葉萃取物用於治療色素沉積綜合症之用途 | |
Fernandes | Evolution of cosmeceuticals and their application to skin disorders, including aging and blemishes | |
KR20200056366A (ko) | 흉터의 예방 또는 치료를 위한 조성물 | |
CN116035997A (zh) | 一种纯天然祛斑美白液的配制工艺及使用方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20100728 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA MK RS |
|
DAX | Request for extension of the european patent (deleted) | ||
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61Q 7/00 20060101ALI20130321BHEP Ipc: A61K 8/98 20060101ALI20130321BHEP Ipc: A61K 31/355 20060101ALI20130321BHEP Ipc: A61Q 19/08 20060101ALI20130321BHEP Ipc: A61K 35/14 20060101AFI20130321BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20130403 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20130903 |